30 Day

Ceribundi Sleep Concentrate Quality Sleep Protocol

STUDY TITLE	Ceribundi Sleep Concentrate Quality Sleep Protocol
Submitted under umbrella	Minimal Risk Citizen Science Umbrella Protocol
Date submitted	-
End date	There is no pre-specified end date and sub-studies remain open long-term.
Language	English
Efforia AI IRB approval recommendation
Recruitment page preview	Preview
Author edit	Edit
Informed consent	Review
Study author	Alina Belaya, Matthew Amsden
Principal investigator	Matthew Amsden
Sub-Investigator for Adverse Events	Dr. Viral Patel
Description	The protocol involves daily consumption of Ceribundi Sleep, a tart cherry juice concentrate enriched with melatonin and magnesium. This intervention aims to enhance sleep quality and overall restfulness. The concentrate's compact size allows for easy integration into the participant's evening routine.
Participant engagement length	30 Days
Sponsor	This study is made possible by your payment to cover all supplies and expenses required to participate.
Cost to participant	$81
Included products & services
Outcome measures
Methodology	Single Arm longitudinal where participants act as their own control
Basic or advanced dissemination plan	Basic
Deviation from recruitment approach	No
Deviation from statistical approach	No
Will study include “more about you questions”	Yes
Recruitment jurisdictions	United States, United Kingdom
Clinicaltrials.Gov	Yes
Committment to list findings on clinicaltrials.Gov	Yes

This document is prepared with the assistance of AI, but is reviewed by a human.

Rational & Study Design

Date	Event	Message	Name